NCT02460094 Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy Status COMPLETED Phase PHASE1
NCT02459886 Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease Status COMPLETED Phase PHASE1
NCT02454907 The Use of Technology to Improve MS Clinical Trials and Patient Care Status ACTIVE_NOT_RECRUITING Phase NA
NCT02443740 Safety, Tolerability and Pharmacokinetics of BIIB118 (PF-05251749) Status COMPLETED Phase PHASE1
NCT02440126 Longitudinal Analysis And Sample Collection To Evaluate PML Risk Host Markers for PML Risk Host Markers for PML Risk Status COMPLETED Phase N/A
NCT02434718 Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT02430532 BG00012 and Delay of Disability Progression in Secondary Progressive Multiple Sclerosis Status TERMINATED Phase PHASE3
NCT02428218 Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) Status WITHDRAWN Phase PHASE3
NCT02422407 A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome Status COMPLETED Phase N/A
NCT02410278 Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera Status COMPLETED Phase PHASE4
NCT02410200 Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS Status COMPLETED Phase PHASE2
NCT02386566 Observational Study to Assess the Correlation of EDSS With Quality of Life in MS Participants Treated With Natalizumab Status COMPLETED Phase N/A
NCT02386553 A Study of Multiple Doses of Nusinersen (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy Status COMPLETED Phase PHASE2
NCT02369224 Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics Status COMPLETED Phase N/A
NCT02359344 PK & Tolerability of CNV1014802 in Young and Elderly Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02343159 Study to Evaluate Whether a Medication Event Monitoring System (MEMS) Can Improve Adherence to Tecfidera Treatment in Multiple Sclerosis Patients. Status TERMINATED Phase PHASE4
NCT02342704 Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants Status TERMINATED Phase PHASE4
NCT02341482 A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of PF-04958242 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02332798 Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia Status COMPLETED Phase PHASE1